Aspect Analytics NV

Founded in 2018 and based in Genk, Belgium, Analytics NV offers a specialized spatial multi-omics platform that integrates diverse biological data, facilitating advanced analyses for researchers in academia and the pharmaceutical sector. Aspect Analytics specializes in a spatial multi-omics platform designed to integrate and analyze various types of biological data. The core product offerings allow teams to bring together multi-omics data—such as genomics, transcriptomics, proteomics, and metabolomics—into a unified, collaborative interface. This platform facilitates in-depth spatial analyses and visualization, enabling researchers in academia, pharmaceutical companies, and contract research organizations (CROs) to derive insights from complex datasets. The system supports the integration of data from different technologies and vendors, accommodating multiple data formats. Aspect Analytics’ solutions are particularly relevant for applications in drug development, biomarker discovery, and pathology analysis, serving clients primarily in North America, Europe, and Asia-Pacific. specific revenue figures are not disclosed, the company operates on a model that includes subscription-based access to its platform alongside custom solutions tailored to user-specific needs. Transactions typically involve partnerships with clients in the pharmaceutical and academic sectors, where teams may subscribe to the platform for ongoing access to its spatial multi-omics capabilities. The pricing structure accommodates both individual users and larger research teams, potentially incorporating fees for advanced features or additional data storage.

1. Series A

   Sep 17, 2025

   Amount

   $5.3M

   Investors

   Locked